These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35912197)

  • 121. A nomogram combining thoracic CT and tumor markers to predict the malignant grade of pulmonary nodules ≤3 cm in diameter.
    Qiu J; Li R; Wang Y; Ma X; Qu C; Liu B; Yue W; Tian H
    Front Oncol; 2023; 13():1196883. PubMed ID: 37361581
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma.
    Liu W; Zhang Q; Zhang T; Li L; Xu C
    Front Oncol; 2022; 12():1090544. PubMed ID: 36620572
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Nomogram-based prognostic tool for stage IIIB/IV non-small cell lung cancer patients undergoing traditional Chinese medicine treatment.
    Liu Y; Ma H; Zhou R; Chen Y; Zhu Y; Chang X; Chen J; Zhang H
    Heliyon; 2024 May; 10(10):e31449. PubMed ID: 38818171
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Prognostic factors of resectable anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) patients: a retrospective analysis based on a single center.
    Zeng A; Xiong Y; Zhang J; Yu H; Zhang L; Bian D; Han L; Wang J; Chen Y; Shaik MS; Zhang P; Dai J
    Transl Lung Cancer Res; 2024 Jan; 13(1):16-33. PubMed ID: 38405002
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
    Li R; Qiu J; Li Z; Li H; Tang Z; Yu W; Tian H; Sun Z
    World J Surg Oncol; 2024 Jan; 22(1):32. PubMed ID: 38273367
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Computed tomography imaging and clinical characteristics of pulmonary ground-glass nodules ≤2 cm with micropapillary pattern.
    Guo CR; Xu L; Li X; Fu YL; Wang H; Han R; Li GS; Feng Z; Li M; Ren WG; Peng ZM
    Thorac Cancer; 2023 Dec; 14(35):3433-3444. PubMed ID: 37876115
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component.
    Li P; Liu L; Wang D; Yang R; Xuan Y; Han Y; Wang J; Guo L; Zhang L; Zhang S; Wang Y
    Front Oncol; 2022; 12():989349. PubMed ID: 36457500
    [TBL] [Abstract][Full Text] [Related]  

  • 128. A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time.
    Karita R; Suzuki H; Onozato Y; Kaiho T; Inage T; Ito T; Tanaka K; Sakairi Y; Yoshino I
    Surg Today; 2024 Jan; 54(1):31-40. PubMed ID: 37129682
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Is there significance in identification of non-predominant micropapillary or solid components in early-stage lung adenocarcinoma?
    Zhao ZR; To KF; Mok TS; Ng CS
    Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):121-125. PubMed ID: 27600912
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Genomics Analysis and Nomogram Risk Prediction of Occult Lymph Node Metastasis in Non-Predominant Micropapillary Component of Lung Adenocarcinoma Measuring ≤ 3 cm.
    Wang K; Xue M; Qiu J; Liu L; Wang Y; Li R; Qu C; Yue W; Tian H
    Front Oncol; 2022; 12():945997. PubMed ID: 35912197
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Predicting occult lymph node metastasis by nomogram in patients with lung adenocarcinoma ≤2 cm.
    Wang Z; Wu Y; Wang L; Gong L; Han C; Liang N; Li S
    Future Oncol; 2021 Jun; 17(16):2005-2013. PubMed ID: 33784826
    [TBL] [Abstract][Full Text] [Related]  

  • 132. The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm.
    Zhang H; Huang W; Liu C; Giaccone G; Zhao X; Sun X; Li J; Cheng R; Huang Q; Mo H; Zhang Z; Zhang B; Wang C
    Front Oncol; 2021; 11():657506. PubMed ID: 34026636
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller.
    Hung JJ; Yeh YC; Jeng WJ; Wu YC; Chou TY; Hsu WH
    Eur J Cardiothorac Surg; 2016 Aug; 50(2):329-36. PubMed ID: 26819290
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Occult lymph node metastasis is not a favorable factor for resected NSCLC patients.
    Cai JS; Yang F; Wang X
    BMC Cancer; 2023 Sep; 23(1):822. PubMed ID: 37667180
    [TBL] [Abstract][Full Text] [Related]  

  • 135. The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma.
    Xue M; Liu J; Li Z; Lu M; Zhang H; Liu W; Tian H
    BMC Cancer; 2024 Jan; 24(1):139. PubMed ID: 38287300
    [TBL] [Abstract][Full Text] [Related]  

  • 136.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 137.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.